Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cerebral Autoregulation in Pediatric ECMO (ECMOX 2) : Autoregul ECMO - ECMOX2

NCT04548739 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT04548739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04548739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cerebral Autoregulation in Pediatric ECMO (ECMOX 2) : Autoregul ECMO - ECMOX2
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Completed
Start date
October 22, 2020
Completion date
October 16, 2023
Enrollment
132 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome (ards), cardiac arrest, cardiogenic shock